Preventing Respiratory Viral Illness Invisibly
Launched by KENNETH ROCKWOOD · Oct 6, 2021
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
Background: Nova Scotia has the highest proportion of seniors in Canada. Investing in high quality and safe long-term care homes is considered an important healthy aging strategy both here and globally. COVID-19 has disproportionately affected the elderly population, especially those with underlying health conditions. Residents of long-term care (LTC) facilities have been particularly vulnerable during this pandemic in Canada and elsewhere. Several approaches have been mandated to mitigate the high transmissibility of the aerosolised SARS-CoV-2 coronavirus. These are guided by three key pri...
Gender
ALL
Eligibility criteria
- • Exclusion Criteria: LTC residents who do not consent to data collection
About Kenneth Rockwood
Kenneth Rockwood is a distinguished clinical trial sponsor with a robust focus on advancing geriatric medicine and improving health outcomes for older adults. With a commitment to innovative research, he spearheads studies that explore the complexities of aging, cognitive decline, and multimorbidity. Leveraging a wealth of experience in clinical geriatrics, Dr. Rockwood's work emphasizes evidence-based approaches to enhance patient care and inform healthcare policies. His contributions to the field are marked by a dedication to fostering collaborations that bridge academia and clinical practice, ultimately striving to translate research findings into tangible benefits for the aging population.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Halifax, Nova Scotia, Canada
Windsor, Nova Scotia, Canada
Sydney, Nova Scotia, Canada
Patients applied
Trial Officials
Kenneth Rockwood, MD
Principal Investigator
Nova Scotia Health Authority
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials